BD — Fiscal 2026 Earnings Summary

BD reported fourth-quarter fiscal 2026 revenue of $5.3 billion, representing a 5.4% increase as reported, while full-year revenue reached $19.5 billion with a 4.9% growth. The company achieved adjusted diluted earnings per share of $4.15 for the quarter and $12.70 for the full year, alongside a 30.0% increase in cash from continuing operations to $3.6 billion. Following the separation of its Life Sciences business, BD announced a $19 billion investment plan in U.S. manufacturing and supply chain resilience in partnership with the U.S. Government. The company issued fiscal 2027 guidance projecting low single-digit revenue growth and adjusted diluted earnings per share between $13.10 and $13.30.